Li R - Search Results

1

Biocharacterization of Heat Shock Protein 90 in Acetaminophen-Treated Livers Without Conspicuous Drug Induced Liver Injury.

Wu K, Guo C, Su M, Wu X, Li R. Wu K, et al. Among authors: li r. Cell Physiol Biochem. 2017;43(4):1562-1570. doi: 10.1159/000482003. Epub 2017 Oct 16. Cell Physiol Biochem. 2017. PMID: 29035890 Free article.

2

FGF21 functions as a sensitive biomarker of APAP-treated patients and mice.

Li R, Guo C, Wu X, Huang Z, Chen J. Li R, et al. Oncotarget. 2017 Jul 4;8(27):44440-44446. doi: 10.18632/oncotarget.17966. Oncotarget. 2017. PMID: 28591702 Free PMC article.

3

Potential biomarker of fibroblast growth factor 21 in valproic acid-treated livers.

Xu X, Guo C, Liang X, Li R, Chen J. Xu X, et al. Among authors: li r. Biofactors. 2019 Sep;45(5):740-749. doi: 10.1002/biof.1519. Epub 2019 May 23. Biofactors. 2019. PMID: 31120577

4

Clinical biocharacterization of immunophenotype in hepatocellular carcinoma patients.

Pan Q, Zhou R, Su M, Wu X, Li R. Pan Q, et al. Among authors: li r. Int J Clin Exp Pathol. 2017 Jul 1;10(7):7670-7673. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966612 Free PMC article.

5

Puerarin exerts the protective effect against chemical induced dysmetabolism in rats.

Li R, Song J, Wu W, Wu X, Su M. Li R, et al. Gene. 2016 Dec 31;595(2):168-174. doi: 10.1016/j.gene.2016.09.036. Epub 2016 Sep 24. Gene. 2016. PMID: 27677221

6

Valproate acid (VPA)-induced dysmetabolic function in clinical and animal studies.

Li R, Liang L, Wu X, Ma X, Su M. Li R, et al. Clin Chim Acta. 2017 May;468:1-4. doi: 10.1016/j.cca.2017.01.030. Epub 2017 Feb 2. Clin Chim Acta. 2017. PMID: 28161274

7

Clinical immunophenotype of nasopharyngeal neuroendocrine carcinoma with metastatic liver cancer.

Guo C, Pan Q, Su M, Li R. Guo C, et al. Among authors: li r. Clin Chim Acta. 2017 Aug;471:283-285. doi: 10.1016/j.cca.2017.06.016. Epub 2017 Jun 17. Clin Chim Acta. 2017. PMID: 28633928

8

Clinical characterization of icotinib-induced chemoresistance in erlotinib-treated lung adenocarcinoma patient with EGFR mutations: A case report.

Wu K, Guo C, Li R. Wu K, et al. Among authors: li r. Medicine (Baltimore). 2019 May;98(18):e15489. doi: 10.1097/MD.0000000000015489. Medicine (Baltimore). 2019. PMID: 31045832 Free PMC article.

9

Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin.

Qin X, Huang C, Wu K, Li Y, Liang X, Su M, Li R. Qin X, et al. Among authors: li y, li r. J Cell Mol Med. 2021 Jan;25(2):677-685. doi: 10.1111/jcmm.16117. Epub 2020 Nov 26. J Cell Mol Med. 2021. PMID: 33241658 Free PMC article.

10

Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma.

Zhou R, Wu K, Su M, Li R. Zhou R, et al. Among authors: li r. Environ Toxicol Pharmacol. 2019 Aug;70:103200. doi: 10.1016/j.etap.2019.103200. Epub 2019 May 27. Environ Toxicol Pharmacol. 2019. PMID: 31158732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35,306 results

Search Page

Filters